Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @EthanBasch1
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EthanBasch1
-
Ethan Basch proslijedio/la je Tweet
Important work from
@EthanBasch1 and@BiostatGirl studying clinician vs patient reporting of baseline and postbaseline symptoms for adverse event assessment in#cancer#clinicaltrials. https://jamanetwork.com/journals/jamaoncology/fullarticle/2757517?guestAccessKey=87549733-8250-4175-8816-f7b05a639e2d&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamaoncology&utm_content=olf&utm_term=122619 …@JAMANetwork@JAMAOnc#hpm#palloncpic.twitter.com/gpvHheI3AK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ethan Basch proslijedio/la je Tweet
For those who are between 18-30 years old and smoke cigarettes, please take part in this
#survey on Scientific Communication & Public Perception of Cancer Research. To my followers, please retweet.#smoking http://j.mp/31zD3HVHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kudos to
@CMSinnovates, for again championing patient-centered cancer care, by including patient-reported outcomes as a key tenet in their draft plan for the “Oncology Care First Model”, to succeed the OCM. Write in to tell them this is a great idea: https://innovation.cms.gov/Files/x/ocf-informalrfi.pdf …pic.twitter.com/SEBMYYBQLD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ethan Basch proslijedio/la je Tweet
Excited for our (Bryce Morrow,
@DavidGotz@trevmanz@ngehlenborg)#IEEEVis Best Paper
for Periphery Plots funded by @NIBIBgov R01: a new way to view & discover patterns in multivariate time series across time scales.@UNC_SOM@HarvardDBMI@unccs@uncsils https://github.com/PrecisionVISSTA/PeripheryPlots …pic.twitter.com/nhZiVLZa9mHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Medicare patients have no cap on their out-of-pocket costs for oral cancer drugs with a back-breaking burden — amidst unimpressive efficacy and high toxicity for many of these drugs.
@DusetzinaS speaks at@corp_UNC Breakfast Seminar. Stop the madness!@HannaSanoffpic.twitter.com/0PxvAA8Lsz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ethan Basch proslijedio/la je Tweet
Impressive use of ePROs in clinical practice! Presentation by Dr. Lotte Haverman reporting feedback on presenting PROMIS items and graphics to clinicians.
#ISOQOL19#PROMIS#HRQL@KLIKprojectpic.twitter.com/HAl21ohOYF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ethan Basch proslijedio/la je Tweet
39% of patients in PRO-TECT trial (follow-up to
@EthanBasch1‘s landmark trial showing ePROs leading to survival benefit) chose automated phone-based ePROs over web. Differences in demographics, completion, and alerts btwn groups.#ISOQOL19#HRQL#ePRO@Angela_M_Stover@corp_UNCpic.twitter.com/531XpTi4XB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ethan Basch proslijedio/la je Tweet
I have collected a list of my favorite guides to aspects of academic life. Please @ me if you know of others that should be added (apologies in advance if, in the interest of parsimony, I don't include them all). Link here:https://www.dropbox.com/s/e9t1o9n8kfnqvzb/Resources%20for%20Academics.docx …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ethan Basch proslijedio/la je Tweet
Yes! "Without PRO data, real-world evidence will not actually reflect how real patients experience real therapies in the real world." Harnessing the patient voice in real-world evidence: ... https://www.nature.com/articles/d41573-019-00088-7 …
@corp_UNC#bcsm@EthanBasch1@UNC_Lineberger#patientvoiceHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Insightful analysis of Pharmacy Benefits Managers (PBMs) by
@tjroycemd at@corp_UNC seminar: obstructions to access, negative effects on quality and patient experience, intentional obscuring of pricing - amidst enormous profits. Work as@ASCO Policy Fellowhttps://jamanetwork.com/journals/jama/fullarticle/2736972 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ethan Basch proslijedio/la je Tweet
Today’s draft guidance is our second in a series of guidance documents that provide clarity to stakeholders how patient experience data can be collected and used for medical product development and in regulatory decision making.
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ethan Basch proslijedio/la je Tweet
FDA is committed to incorporating the patient voice in drug development. Today we issued a draft guidance on patient focused drug development, which focuses on methods to identify what matters most to patients regarding their disease & treatment https://go.usa.gov/xVGpt pic.twitter.com/VrmHN7x2rH
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Proud of new
@JAMAOnc paper with@BiostatGirl,@GitaThanaMD, and@bennettphd showing PRO-CTCAE improves accuracy and patient-centeredness of adverse event reporting in phase III cancer clinical trial@NCICareDelivRes@NCICancerCtrl@NCI_ImplScihttps://jamanetwork.com/journals/jamaoncology/fullarticle/2751871?guestAccessKey=a140e566-1d25-49c3-96a5-f8c7cdd876b1&utm_source=jps&utm_medium=email&utm_campaign=author_alert-jamanetwork&utm_content=author-author_engagement&utm_term=1m …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ethan Basch proslijedio/la je Tweet
Fascinating work in
@JAMAOnc by@BiostatGirl and@EthanBasch1 investigating patient-reported and investigator-reported symptomatic adverse events. https://jamanetwork.com/journals/jamaoncology/fullarticle/2751871 …#PallOnc#PROs#PatientExperiencepic.twitter.com/PkWADj7BhZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ethan Basch proslijedio/la je Tweet
Podcast: Dr.
@EthanBasch1 Highlights Key Presentations from the ASCO Quality Care Symposium: http://bit.ly/2mPCXNq#ASCOdailynews#ASCOQLTY19#cancercareHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ethan Basch proslijedio/la je Tweet
We’re seeking volunteers with a commitment to cancer education to help enhance our learning portfolio. Apply to our Education Scholars Program by tomorrow at 11:59 PM ET! https://fal.cn/345tq pic.twitter.com/HlyMaJB2y5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ethan Basch proslijedio/la je Tweet
This is disturbing...... PRO-CTCAE is patient reported symptom monitoring developed to measure what matters to patients... I thought for 'open' use... Can this be changed?
#PROsForPatients#bcsm#lcsm#mmsm@Lymphomation@pkluetz@BellKingKal@NCIadvocacy@deborahcollyarhttps://twitter.com/EthanBasch1/status/1173696864287371264 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ethan Basch proslijedio/la je Tweet
Thx for alerting us. PRO-CTCAE should be used in ALL settings.
@theNCI should know this, as should#healthcare#Systems.#EHR need this so Real World#Data can help all#patients!#NCI#NIH, please change, for#patient sake!@US_FDA, help!#bcsmhttps://twitter.com/EthanBasch1/status/1173969264702701569 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ethan Basch proslijedio/la je Tweet
BAM! Get em girl! So impressed by
@angiesmith_urohttps://twitter.com/OoR_UNC/status/1174337845495881730 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The mighty
@uncprocore development team, looking sharp as they build the future of patient-reported outcomes software systems!@UNC_Lineberger@corp_UNC#PRO https://pro.unc.edu/about.php pic.twitter.com/tyTOLCLZuJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.